Osteoporosis is diagnosed with a bone density scan, not a blood test. Lab testing plays a different but essential role: it looks for hidden causes of bone loss, checks that it is safe to start treatment, and can show whether treatment is working. A standard panel usually includes calcium, vitamin D, kidney and liver function, and often parathyroid hormone and thyroid tests.
In this guide I walk through which tests are ordered, what the normal ranges are, and how the results change the plan. Bone health sits at the border of endocrinology and haematology, and several of the most important “secondary” causes of osteoporosis are picked up through ordinary blood work.
What Osteoporosis Is and How It Is Diagnosed
Osteoporosis is a skeletal condition in which bone mass falls and its internal architecture deteriorates, so bones break from minor falls or even everyday strain. Bone is constantly remodeled: osteoclasts break old bone down and osteoblasts build new bone. When resorption outpaces formation for years, bone becomes thin and fragile.
It is often called a silent disease because there are no symptoms until a fracture happens, most commonly at the hip, spine, or wrist. Loss of height or a stooped posture may be the first clue to spinal compression fractures.
The formal diagnosis rests on a DXA scan (dual-energy X-ray absorptiometry), reported as a T-score comparing your bone density with that of a healthy young adult. Osteoporosis can also be diagnosed clinically after a fragility fracture of the hip or spine, regardless of the scan result.
| DXA T-score | Classification |
|---|---|
| -1.0 or higher | Normal bone density |
| Between -1.0 and -2.5 | Low bone mass (osteopenia) |
| -2.5 or lower | Osteoporosis |
| -2.5 or lower plus a fragility fracture | Severe (established) osteoporosis |
Why Lab Tests Matter in Osteoporosis
Most osteoporosis is primary, driven by aging and, in women, the fall in estrogen after menopause. But a meaningful share of patients have secondary osteoporosis, where another condition or medication is causing the bone loss. Treating that cause can be as important as any bone drug.
Lab work is especially important in men, in premenopausal women, in anyone with unusually low bone density for their age, and in children. The evaluation of juvenile osteoporosis, for example, relies heavily on labs to exclude underlying disease.
Blood tests also answer practical safety questions. Bisphosphonates should not be given to someone with low calcium or significantly reduced kidney function, and vitamin D deficiency should be corrected before most treatments begin.
The Core Osteoporosis Lab Panel
The table below shows the tests most often ordered in an initial workup, with typical adult reference ranges. Exact ranges vary slightly between laboratories.
| Test | Typical adult range | What an abnormal result suggests |
|---|---|---|
| Serum calcium | 8.5–10.5 mg/dL (2.1–2.6 mmol/L) | High: hyperparathyroidism or malignancy. Low: vitamin D deficiency, malabsorption |
| Phosphate | 2.5–4.5 mg/dL | Low: osteomalacia or vitamin D problems |
| 25-hydroxyvitamin D | Sufficient at 30 ng/mL (75 nmol/L) or above in most bone guidelines; below 20 ng/mL is deficient | Low levels impair calcium absorption and mineralization |
| Parathyroid hormone (PTH) | About 10–65 pg/mL | High with high calcium: primary hyperparathyroidism. High with low or normal calcium: secondary, often vitamin D deficiency |
| Alkaline phosphatase | About 44–147 IU/L | High: osteomalacia, Paget disease, recent fracture, or liver disease |
| Creatinine / eGFR | eGFR above 60 mL/min/1.73m² | Reduced kidney function alters mineral metabolism and drug choice |
| TSH | About 0.4–4.0 mIU/L | Low: hyperthyroidism or excess thyroid replacement, both accelerate bone loss |
| Complete blood count | Standard ranges | Anemia may point to myeloma, celiac disease, or chronic illness |
Additional tests in selected patients
- Serum and urine protein electrophoresis: screens for multiple myeloma, a blood cancer that destroys bone, particularly when there is anemia, high calcium, or vertebral fractures.
- 24-hour urine calcium: detects excessive calcium loss through the kidneys.
- Celiac serology (tissue transglutaminase antibodies): celiac disease causes malabsorption of calcium and vitamin D.
- Testosterone in men and estradiol or FSH in younger women: sex hormone deficiency is a common secondary cause.
- Cortisol testing: when Cushing syndrome is suspected.
Bone Turnover Markers
Bone turnover markers are substances released into the blood or urine as bone is broken down or built. They do not diagnose osteoporosis, but they show how active remodeling is.
- Resorption markers: serum C-telopeptide (CTX) and urinary N-telopeptide (NTX), fragments of collagen released when osteoclasts break down bone.
- Formation markers: procollagen type 1 N-terminal propeptide (P1NP), osteocalcin, and bone-specific alkaline phosphatase.
Their main use is monitoring. After starting an antiresorptive drug such as a bisphosphonate, CTX should fall noticeably within a few months, which reassures both doctor and patient that the medicine is being absorbed and working. CTX must be taken fasting in the morning because it varies with meals and time of day.
How Lab Results Shape Treatment
Once the labs are back, the plan becomes clearer. Vitamin D deficiency is corrected first. Primary hyperparathyroidism may be referred for surgery, which itself improves bone density. Thyroid over-replacement is adjusted, and celiac disease is managed with a gluten-free diet.
For primary osteoporosis, bisphosphonates such as alendronate are commonly first-line. Denosumab is an alternative, including in some patients with reduced kidney function. Anabolic agents such as teriparatide and romosozumab build new bone and are generally reserved for people at very high fracture risk.
Adequate calcium and vitamin D underpin every treatment. The evidence on supplements in osteoporosis management supports correcting deficiency rather than taking high doses indiscriminately. Weight-bearing exercise, stopping smoking, limiting alcohol, and preventing falls all matter too. For people already living with fractures, osteoporosis pain treatment is an important part of care.
Key Takeaways
- A DXA scan diagnoses osteoporosis; blood tests search for causes and guide safe treatment.
- The core panel includes calcium, phosphate, vitamin D, PTH, alkaline phosphatase, kidney function, TSH, and a blood count.
- Secondary causes such as hyperparathyroidism, myeloma, celiac disease, and hormone deficiency are found through labs.
- Bone turnover markers such as CTX and P1NP help monitor whether treatment is working.
For a broader overview, see our osteoporosis guide.
Frequently Asked Questions
Can a blood test diagnose osteoporosis?
No. Blood tests are usually normal in primary osteoporosis. The diagnosis comes from a DXA scan or from a fragility fracture, while blood tests look for underlying causes and check treatment safety.
Do I need to fast before osteoporosis blood tests?
Most routine tests do not require fasting. Bone turnover markers, especially CTX, should be drawn fasting in the early morning, and your doctor may bundle the whole panel into one fasting visit for convenience.
How often should labs be repeated during treatment?
Vitamin D is often rechecked a few months after starting supplements. Kidney function and calcium are checked periodically, particularly on bisphosphonates or denosumab. Bone turnover markers may be repeated three to six months after starting therapy.
Why would a hematologist be involved in osteoporosis?
Some blood disorders damage bone directly, most notably multiple myeloma, and others such as thalassemia or systemic mastocytosis are linked to bone loss. Unexplained anemia or abnormal protein studies during an osteoporosis workup usually prompt a hematology referral.
